Overview
KLOW is a five-component research blend combining KPV, BPC-157, TB-500, GHK-Cu, and larazotide acetate in a single lyophilized vial.
Why combine these five
Each component is independently studied for different repair pathways: KPV (anti-inflammatory α-MSH fragment), BPC-157 (angiogenesis and gut-axis signaling), TB-500 (actin sequestration), GHK-Cu (copper-peptide collagen support), and larazotide (tight-junction modulation). KLOW lets researchers study them together as a stack rather than running parallel single-compound preparations.
Notes for the lab
Reconstitute with 2–3 mL bacteriostatic water for an 80 mg vial; the blend is water-soluble. Storage and freeze-thaw constraints follow the most fragile component — keep refrigerated after reconstitution and aliquot for longer storage.